Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 Nov;53(11):979–983. doi: 10.1136/thx.53.11.979

Somatic mutations in the development of lung cancer

M Roland 1, R Rudd 1
PMCID: PMC1745123  PMID: 10193399

Full Text

The Full Text of this article is available as a PDF (84.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auerbach O., Hammond E. C., Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med. 1979 Feb 22;300(8):381–385. doi: 10.1056/NEJM197902223000801. [DOI] [PubMed] [Google Scholar]
  2. Chiba I., Takahashi T., Nau M. M., D'Amico D., Curiel D. T., Mitsudomi T., Buchhagen D. L., Carbone D., Piantadosi S., Koga H. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene. 1990 Oct;5(10):1603–1610. [PubMed] [Google Scholar]
  3. Chung G. T., Sundaresan V., Hasleton P., Rudd R., Taylor R., Rabbitts P. H. Clonal evolution of lung tumors. Cancer Res. 1996 Apr 1;56(7):1609–1614. [PubMed] [Google Scholar]
  4. Chung G. T., Sundaresan V., Hasleton P., Rudd R., Taylor R., Rabbitts P. H. Sequential molecular genetic changes in lung cancer development. Oncogene. 1995 Dec 21;11(12):2591–2598. [PubMed] [Google Scholar]
  5. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol. 1995 Sep;147(3):545–560. [PMC free article] [PubMed] [Google Scholar]
  6. Doll R., Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J. 1976 Dec 25;2(6051):1525–1536. doi: 10.1136/bmj.2.6051.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FOULDS L. The natural history of cancer. J Chronic Dis. 1958 Jul;8(1):2–37. doi: 10.1016/0021-9681(58)90039-0. [DOI] [PubMed] [Google Scholar]
  8. Fearon E. R. The smoking gun and the damage done: genetic alterations in the lungs of smokers. J Natl Cancer Inst. 1997 Jun 18;89(12):834–836. doi: 10.1093/jnci/89.12.834. [DOI] [PubMed] [Google Scholar]
  9. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  10. Flehinger B. J., Melamed M. R., Zaman M. B., Heelan R. T., Perchick W. B., Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis. 1984 Oct;130(4):555–560. doi: 10.1164/arrd.1984.130.4.555. [DOI] [PubMed] [Google Scholar]
  11. Fontana R. S., Sanderson D. R., Taylor W. F., Woolner L. B., Miller W. E., Muhm J. R., Uhlenhopp M. A. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984 Oct;130(4):561–565. doi: 10.1164/arrd.1984.130.4.561. [DOI] [PubMed] [Google Scholar]
  12. Frost J. K., Ball W. C., Jr, Levin M. L., Tockman M. S., Baker R. R., Carter D., Eggleston J. C., Erozan Y. S., Gupta P. K., Khouri N. F. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984 Oct;130(4):549–554. doi: 10.1164/arrd.1984.130.4.549. [DOI] [PubMed] [Google Scholar]
  13. Fujiwara T., Cai D. W., Georges R. N., Mukhopadhyay T., Grimm E. A., Roth J. A. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst. 1994 Oct 5;86(19):1458–1462. doi: 10.1093/jnci/86.19.1458. [DOI] [PubMed] [Google Scholar]
  14. Geddes D. M. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest. 1979 Jan;73(1):1–17. [PubMed] [Google Scholar]
  15. George P. J. Delays in the management of lung cancer. Thorax. 1997 Feb;52(2):107–108. doi: 10.1136/thx.52.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Georges R. N., Mukhopadhyay T., Zhang Y., Yen N., Roth J. A. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res. 1993 Apr 15;53(8):1743–1746. [PubMed] [Google Scholar]
  17. Halpern M. T., Gillespie B. W., Warner K. E. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993 Mar 17;85(6):457–464. doi: 10.1093/jnci/85.6.457. [DOI] [PubMed] [Google Scholar]
  18. Harpole D. H., Jr, Herndon J. E., 2nd, Wolfe W. G., Iglehart J. D., Marks J. R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res. 1995 Jan 1;55(1):51–56. [PubMed] [Google Scholar]
  19. Hung J., Kishimoto Y., Sugio K., Virmani A., McIntire D. D., Minna J. D., Gazdar A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA. 1995 Feb 15;273(7):558–563. [PubMed] [Google Scholar]
  20. Kanters S. D., Lammers J. W., Voest E. E. Molecular and biological factors in the prognosis of non-small cell lung cancer. Eur Respir J. 1995 Aug;8(8):1389–1397. doi: 10.1183/09031936.95.08081389. [DOI] [PubMed] [Google Scholar]
  21. Kern J. A., Slebos R. J., Top B., Rodenhuis S., Lager D., Robinson R. A., Weiner D., Schwartz D. A. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J Clin Invest. 1994 Feb;93(2):516–520. doi: 10.1172/JCI117001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kishimoto Y., Sugio K., Hung J. Y., Virmani A. K., McIntire D. D., Minna J. D., Gazdar A. F. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst. 1995 Aug 16;87(16):1224–1229. doi: 10.1093/jnci/87.16.1224. [DOI] [PubMed] [Google Scholar]
  23. Knudson A. G., Jr Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985 Apr;45(4):1437–1443. [PubMed] [Google Scholar]
  24. Lam S., MacAulay C., Hung J., LeRiche J., Profio A. E., Palcic B. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg. 1993 Jun;105(6):1035–1040. [PubMed] [Google Scholar]
  25. Lowe S. W., Ruley H. E., Jacks T., Housman D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993 Sep 24;74(6):957–967. doi: 10.1016/0092-8674(93)90719-7. [DOI] [PubMed] [Google Scholar]
  26. Mao L., Hruban R. H., Boyle J. O., Tockman M., Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 1994 Apr 1;54(7):1634–1637. [PubMed] [Google Scholar]
  27. Mao L., Lee J. S., Kurie J. M., Fan Y. H., Lippman S. M., Lee J. J., Ro J. Y., Broxson A., Yu R., Morice R. C. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997 Jun 18;89(12):857–862. doi: 10.1093/jnci/89.12.857. [DOI] [PubMed] [Google Scholar]
  28. Mills N. E., Fishman C. L., Rom W. N., Dubin N., Jacobson D. R. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 1995 Apr 1;55(7):1444–1447. [PubMed] [Google Scholar]
  29. Nau M. M., Brooks B. J., Battey J., Sausville E., Gazdar A. F., Kirsch I. R., McBride O. W., Bertness V., Hollis G. F., Minna J. D. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature. 1985 Nov 7;318(6041):69–73. doi: 10.1038/318069a0. [DOI] [PubMed] [Google Scholar]
  30. Nowell P. C. The clonal evolution of tumor cell populations. Science. 1976 Oct 1;194(4260):23–28. doi: 10.1126/science.959840. [DOI] [PubMed] [Google Scholar]
  31. Pezzella F., Turley H., Kuzu I., Tungekar M. F., Dunnill M. S., Pierce C. B., Harris A., Gatter K. C., Mason D. Y. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med. 1993 Sep 2;329(10):690–694. doi: 10.1056/NEJM199309023291003. [DOI] [PubMed] [Google Scholar]
  32. Rabbitts P. H. Genetic changes in the development of lung cancer. Br Med Bull. 1994 Jul;50(3):688–697. doi: 10.1093/oxfordjournals.bmb.a072917. [DOI] [PubMed] [Google Scholar]
  33. Schneider P. M., Hung M. C., Chiocca S. M., Manning J., Zhao X. Y., Fang K., Roth J. A. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res. 1989 Sep 15;49(18):4968–4971. [PubMed] [Google Scholar]
  34. Sidransky D. Importance of chromosome 9p loss in human lung cancer. J Natl Cancer Inst. 1995 Aug 16;87(16):1201–1202. doi: 10.1093/jnci/87.16.1201. [DOI] [PubMed] [Google Scholar]
  35. Slebos R. J., Kibbelaar R. E., Dalesio O., Kooistra A., Stam J., Meijer C. J., Wagenaar S. S., Vanderschueren R. G., van Zandwijk N., Mooi W. J. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med. 1990 Aug 30;323(9):561–565. doi: 10.1056/NEJM199008303230902. [DOI] [PubMed] [Google Scholar]
  36. Smit E. F., Groen H. J., Splinter T. A., Ebels T., Postmus P. E. New prognostic factors in resectable non-small cell lung cancer. Thorax. 1996 Jun;51(6):638–646. doi: 10.1136/thx.51.6.638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Strong M. S., Incze J., Vaughan C. W. Field cancerization in the aerodigestive tract--its etiology, manifestation, and significance. J Otolaryngol. 1984 Feb;13(1):1–6. [PubMed] [Google Scholar]
  38. Takahashi T., Takahashi T., Suzuki H., Hida T., Sekido Y., Ariyoshi Y., Ueda R. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene. 1991 Oct;6(10):1775–1778. [PubMed] [Google Scholar]
  39. Walker C., Robertson L., Myskow M., Dixon G. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer. 1995 Jul;72(1):164–169. doi: 10.1038/bjc.1995.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weiner D. B., Nordberg J., Robinson R., Nowell P. C., Gazdar A., Greene M. I., Williams W. V., Cohen J. A., Kern J. A. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res. 1990 Jan 15;50(2):421–425. [PubMed] [Google Scholar]
  41. Wistuba I. I., Lam S., Behrens C., Virmani A. K., Fong K. M., LeRiche J., Samet J. M., Srivastava S., Minna J. D., Gazdar A. F. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst. 1997 Sep 17;89(18):1366–1373. doi: 10.1093/jnci/89.18.1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wong A. J., Ruppert J. M., Eggleston J., Hamilton S. R., Baylin S. B., Vogelstein B. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science. 1986 Jul 25;233(4762):461–464. doi: 10.1126/science.3014659. [DOI] [PubMed] [Google Scholar]
  43. Xu H. J., Quinlan D. C., Davidson A. G., Hu S. X., Summers C. L., Li J., Benedict W. F. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J Natl Cancer Inst. 1994 May 4;86(9):695–699. doi: 10.1093/jnci/86.9.695. [DOI] [PubMed] [Google Scholar]
  44. Yokota J., Akiyama T., Fung Y. K., Benedict W. F., Namba Y., Hanaoka M., Wada M., Terasaki T., Shimosato Y., Sugimura T. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene. 1988 Oct;3(4):471–475. [PubMed] [Google Scholar]
  45. Yokota J., Wada M., Shimosato Y., Terada M., Sugimura T. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9252–9256. doi: 10.1073/pnas.84.24.9252. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES